Albertsons’ $774 Million Opioid Settlement Signals Continued Accountability for Pharmacy Chains April 14, 2026 Albertsons Companies has agreed to a $774 million opioid settlement framework to resolve claims brought by state, local, and tribal governments nationwide, marking another significant milestone in ongoing litigation aimed at addressing the opioid epidemic. The agreement is part of a broader wave of legal actions alleging that pharmacy chains failed to act as a […] Read More
Chicago Jury Awards $53 Million in Infant Formula NEC Case Against Abbott Laboratories April 10, 2026 Holding Formula Manufacturers Accountable A Cook County, Illinois jury has awarded $53 million dollars in damages to four families who alleged that Abbott Laboratories’ preterm infant formula contributed to their babies developing necrotizing enterocolitis or NEC, a life-threatening gastrointestinal condition that primarily affects premature infants. The verdict marks the first NEC baby formula case to […] Read More
What a Recent Lancet Retraction Means for the Talc Debate March 26, 2026 A recent development has raised new questions about scientific integrity in the ongoing debate over talc and cancer. In March 2026, The Lancet retracted a commentary related to talc and ovarian cancer after concerns were raised about conflicts of interest. The article’s author had ties to industry consulting that were not properly disclosed at the […] Read More
Levin Law
Levin Law